Boehringer Ingelheim completes $76-million expansionOctober 14, 2019Boehringer Ingelheim revealed a $76-million expansion at its manufacturing plant in Athens, Ga., that will double the company’s capacity to produce vaccines for pets.
SPONSORED CONTENTKeep the Blaze at BaySee how an approach that manages the pain AND inflammation of canine OA can benefit your patients + Learn More